“Do not threaten us; let’s talk instead.”

On 8 June, government think-tank Niti Aayog first shared its proposed new price control policy for medical devices with US-headquartered medical device manufacturers. This new approach seeks to change the price control policy from one that currently caps prices on medical devices such as knee implants and stents without any room for flexibility. The new policy aims to cap margins on 18 other devices mentioned in the Drug Price Control Order 2013, instead. It came with the request mentioned above.

The request did not come out of the blue—it was in response to the US’ simmering unhappiness over the existing price control policy.

AUTHOR

Ruhi Kandhari

Ruhi writes on the impact of healthcare policies, trends in the healthcare sector and developments on the implementation of Electronic Health Records in India. She has an M. Sc. in Development Studies from the London School of Economics.

View Full Profile

Sign up to our India edition to read this story instantly

To sign up, you’ll create an account that will give you access to a new free story published once a week and archive of 214+ previously published free stories from our India edition. You’ll also receive one email every morning from us introducing the day’s story.

If you’ve already signed up, just enter your email below or login using Facebook or Google.